MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,078,413 | -33.0% | 48,469 | +6.0% | 0.60% | -52.6% |
| Q2 2023 | $10,565,709 | -72.7% | 45,739 | -65.7% | 1.27% | -78.7% |
| Q4 2022 | $38,693,808 | +269.4% | 133,312 | -17.3% | 5.97% | +191.5% |
| Q3 2022 | $10,474,000 | -0.8% | 161,163 | -4.1% | 2.05% | -0.5% |
| Q2 2022 | $10,554,000 | -30.0% | 168,003 | -22.0% | 2.06% | +12.8% |
| Q1 2022 | $15,072,000 | +6.1% | 215,316 | +28.4% | 1.82% | +11.2% |
| Q4 2021 | $14,208,000 | +8.0% | 167,661 | +1.7% | 1.64% | +0.3% |
| Q3 2021 | $13,154,000 | -18.1% | 164,860 | 0.0% | 1.64% | -50.7% |
| Q2 2021 | $16,059,000 | +21.9% | 164,860 | +46.4% | 3.32% | +0.2% |
| Q1 2021 | $13,171,000 | +4.5% | 112,604 | -0.8% | 3.31% | +40.6% |
| Q4 2020 | $12,608,000 | -7.4% | 113,464 | -1.0% | 2.35% | -46.1% |
| Q3 2020 | $13,614,000 | +2.5% | 114,661 | -2.3% | 4.37% | -3.9% |
| Q2 2020 | $13,288,000 | – | 117,331 | – | 4.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |